Dr. Lloyd Damon, MD

Claim this profile

University of California, San Francisco

Studies Leukemia
Studies Acute Myeloid Leukemia
4 reported clinical trials
7 drugs studied

Area of expertise

1Leukemia
Lloyd Damon, MD has run 4 trials for Leukemia. Some of their research focus areas include:
CEBPA negative
NPM1 negative
Philadelphia chromosome positive
2Acute Myeloid Leukemia
Lloyd Damon, MD has run 3 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
CEBPA negative
NPM1 negative
IDH positive

Affiliated Hospitals

Image of trial facility.
University Of California, San Francisco
Image of trial facility.
UCSF Comprehensive Cancer Center

Clinical Trials Lloyd Damon, MD is currently running

Image of trial facility.

CPX-351 + Glasdegib

for Acute Myeloid Leukemia

This trial is testing a combination of two drugs, CPX-351 and Glasdegib, in patients with a specific type of leukemia that is hard to treat. CPX-351 kills cancer cells, and Glasdegib stops them from growing. The goal is to see if this combination is effective for these patients.
Recruiting3 awards Phase 2

More about Lloyd Damon, MD

Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Lloyd Damon, MD has experience with
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • CPX-351
  • Glasdegib
  • Blinatumomab
  • Pembrolizumab
  • Enasidenib Mesylate
Breakdown of trials Lloyd Damon, MD has run
Leukemia
Acute Myeloid Leukemia
Myeloid Leukemia
Acute Myelogenous Leukemia
Acute Lymphoblastic Leukemia

Other Doctors you might be interested in

Sabine Mueller, MD, PhD, MASUniversity of California, San Francisco
Maria Luisa Gorno Tempini, MD, PhDMemory and Aging Center, University of California, San Francisco
Sue S. YomUniversity of California San Francisco

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lloyd Damon, MD specialize in?
Lloyd Damon, MD focuses on Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Leukemia has involved CEBPA negative patients, or patients who are NPM1 negative.
Is Lloyd Damon, MD currently recruiting for clinical trials?
Yes, Lloyd Damon, MD is currently recruiting for 1 clinical trial in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Lloyd Damon, MD has studied deeply?
Yes, Lloyd Damon, MD has studied treatments such as Liposome-encapsulated Daunorubicin-Cytarabine, CPX-351, Glasdegib.
What is the best way to schedule an appointment with Lloyd Damon, MD?
Apply for one of the trials that Lloyd Damon, MD is conducting.
What is the office address of Lloyd Damon, MD?
The office of Lloyd Damon, MD is located at: University of California, San Francisco, San Francisco, California 94143 United States. This is the address for their practice at the University of California, San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top